SEP 07, 2020 8:00 AM PDT

Spot the Robodog Measures COVID Patients' Vitals

WRITTEN BY: Tara Fernandez

Hospital staff caring for COVID-19 patients face the greatest risk of exposure to the virus. A new dog-like robot designed by researchers at MIT has come to the rescue, promising to minimize face-to-face contact between healthcare staff and infected patients. The use of this agile mobile robotic technology was published in a recent study, showing just how transformative it could be for contactless monitoring of patient vital signs.

“We started to think about how we could protect healthcare providers and minimize contact with folks that might be infectious,” said Giovanni Traverso, senior author of the study. In partnership with Boston Dynamics, the team set about making Spot the robotic dog to work, guiding it to patients using a remote-controlled device.

Spot comes kitted up with a series of cameras: an infrared camera to measure the patient’s temperature, one that detects breathing rate, and others that can track blood flow, pulse rate, and blood oxygen saturation — all without having to make physical contact with the patient.

While Spot’s core technology is not new, the pandemic has presented a unique opportunity to use robots in unprecedented ways within the context of healthcare.

“I think collectively, as a community, what we’re recognizing is that there are many tools out there today from the robotics perspective, the sensor perspective, and really integrating them and really evaluating them in the field and seeing how they perform is part of the next step,” explained Traverso. 

“Really, what we did here is translating a lot of the work that other people have done, but integrating it and asking the question, is this something that could work? How well does it work?” Follow-up studies are focused on improving the precision of Spot’s onboard algorithms for processing patient data and identifying the cost and feasibility of integrating robotic technologies into hospital systems.
 

 Sources: TechRXiv, Fast Company.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 21, 2020
Clinical & Molecular DX
Smart Wearable Patch Signals Trouble Following Traumatic Injury
SEP 21, 2020
Smart Wearable Patch Signals Trouble Following Traumatic Injury
An ambulance pulls up to the site of a car accident, sirens blazing. Paramedics assess the crash victims, looking for si ...
SEP 21, 2020
Cancer
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
SEP 21, 2020
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
Cancer is an incredibly diverse disease. It has many types and even sub-types, with a vast range of characteristics. Som ...
DEC 10, 2020
Clinical & Molecular DX
Gut Feeling: Microbiome Reveals Toxic Chemical Exposure in Kids
DEC 10, 2020
Gut Feeling: Microbiome Reveals Toxic Chemical Exposure in Kids
A study by Duke University researchers has revealed that children’s gut microbiomes hold clues as to their possibl ...
DEC 24, 2020
Clinical & Molecular DX
Feeling Unmotivated? It Could Be Dementia.
DEC 24, 2020
Feeling Unmotivated? It Could Be Dementia.
Apathy, characterized by a pronounced lack of enthusiasm, motivation, or interest, is a predictor of the future onset of ...
DEC 30, 2020
Clinical & Molecular DX
Of Mice and Men: Deep Learning Transforms Diagnostics
DEC 30, 2020
Of Mice and Men: Deep Learning Transforms Diagnostics
Medical imaging technologies enable physicians to take a peek under the hood, capturing snapshots of the internal organs ...
JAN 18, 2021
Cancer
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
JAN 18, 2021
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
Breast cancer is one of the most well-studied cancers in modern medicine. Diagnostics can already differentiate between ...
Loading Comments...